 | Finch Therapeutics Group, Inc. | |||
| NMS : FNCH || Location: United States | ||||
$2.21-0.09 (-3.91%) |
0.04 M | 2.1 - 2.3 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.009 M |
| March 15, 2024 | 0.012 M |
| Feb. 29, 2024 | 0.002 M |
| Feb. 15, 2024 | 0.003 M |
| Jan. 31, 2024 | 0.002 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 06/30/2023 | -4.59 | -3.24 | 29.41% |
| 03/31/2023 | -2.75 | -11.40 | -313.94% |
| 12/31/2022 | -10.40 | -16.80 | -61.48% |
| 09/30/2022 | -12.24 | -25.50 | -108.33% |
| 06/30/2022 | -12.45 | -14.40 | -15.70% |
FNCH Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 1.606M | Shares Float | 0.793M |
| Short Float | 0.009M | Market Cap | 3.69M |
| Institution ownership | 15.02% | Insider ownership | 53.481% |
| Earnings Date | Cash Per Share | ? | |
| Trailing EPS | -46.59 | Forward EPS | -20.59 |